Unravelling phenolic metabotypes in the frame of the COMBAT study, a randomized, controlled trial with cranberry supplementation
Nicole Tosi(University of Parma), Pedro Mena(University of Parma), David Vauzour(University of East Anglia), Daniele Del Rio(University of Parma), Letizia Bresciani(University of Parma), Claudia Favari(University of Parma), Emma Flanagan(The University of Adelaide), Michael Hornberger(University of Southampton), Arjan Narbad(Quadram Institute)
Cited by 19
Related Papers
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
|npj Parkinson s Disease|2021|669
Rapid and Comprehensive Evaluation of (Poly)phenolic Compounds in Pomegranate (Punica granatum L.) Juice by UHPLC-MSn
|Molecules|2012|311
<i>APOE</i> genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology
|The FASEB Journal|2019|227
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
|Molecular Neurodegeneration|2022|205
Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism
|Food & Function|2014|157